Cindy Donaldson

Title: Innovator Spotlight: Cindy Donaldson and Her Patent Impact

Introduction

Cindy Donaldson, based in San Diego, CA, has made significant contributions to the field of pharmacology through her innovative research. With one patent to her name, her work focuses on enhancing drug formulations that may improve therapeutic outcomes.

Latest Patents

Cindy is the inventor of a patent titled "Urocortin 2 analogs and uses thereof." This patent discloses polypeptides that are analogs of urocortin 2, designed to exhibit pharmacological activity similar to urocortin 2 while offering improved water solubility. The patent outlines not only the polypeptides themselves but also pharmaceutical compositions derived from them. Furthermore, it provides details on polynucleotides encoding these polypeptides, methods for treating various pathophysiological conditions using these compositions, and includes vectors and host cells with the nucleic acids as well as kits for practical use.

Career Highlights

Cindy has been associated with the Research Development Foundation, where she has effectively applied her expertise in creating innovative solutions. Her patent reflects her commitment to advancing medical science and improving treatment methodologies for various health conditions.

Collaborations

Throughout her career, Cindy has collaborated with esteemed professionals such as Wylie W Vale, Jr. and Joan M Vaughan. These collaborations have likely fueled her innovative capabilities and contributed to the successful development of her patented technologies.

Conclusion

Cindy Donaldson's work exemplifies the creative spirit and dedication of innovators in the field of medicine. Her patent on Urocortin 2 analogs showcases the potential for new therapeutic options that can greatly benefit patients. As part of the Research Development Foundation, her ongoing contributions continue to inspire advancements in pharmacological research.